| 前收市價 | 5.60 |
| 開市 | 5.60 |
| 買盤 | 5.90 |
| 賣出價 | 6.70 |
| 拍板 | 45.00 |
| 到期日 | 2024-12-20 |
| 今日波幅 | 5.60 - 5.60 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 27 |
ZacksApellis (APLS) Up on Upbeat GA Data From Long-Term Syfovre Study
Apellis (APLS) rises 3.3% as the treatment of GA patients with Syfovre demonstrates a visual function benefit in a prespecified endpoint at month 36 in a late-stage, long-term extension study.
ZacksWhy Is Apellis Pharmaceuticals (APLS) Down 1.9% Since Last Earnings Report?
Apellis Pharmaceuticals (APLS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ZacksApellis (APLS) Posts Upbeat One-Year Kidney Diseases Study Data
Apellis (APLS) reports positive one-year data from the mid-stage study evaluating systemic pegcetacoplan to treat two rare and debilitating kidney diseases.
